Chad R. Baker’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-12,500
| Closed | -$332K | – | 51 |
|
|
2024
Q4 | $332K | Sell |
12,500
-12,000
| -49% | -$325K | 0.06% | 50 |
|
|
2024
Q3 | $709K | Hold |
24,500
| – | – | 0.14% | 49 |
|
|
2024
Q2 | $686K | Hold |
24,500
| – | – | 0.14% | 51 |
|
|
2024
Q1 | $680K | Hold |
24,500
| – | – | 0.14% | 50 |
|
|
2023
Q4 | $705K | Hold |
24,500
| – | – | 0.16% | 47 |
|
|
2023
Q3 | $813K | Hold |
24,500
| – | – | 0.21% | 48 |
|
|
2023
Q2 | $899K | Hold |
24,500
| – | – | 0.21% | 47 |
|
|
2023
Q1 | $1,000K | Hold |
24,500
| – | – | 0.25% | 47 |
|
|
2022
Q4 | $1.25M | Hold |
24,500
| – | – | 0.35% | 45 |
|
|
2022
Q3 | $1.07M | Hold |
24,500
| – | – | 0.31% | 48 |
|
|
2022
Q2 | $1.28M | Hold |
24,500
| – | – | 0.36% | 46 |
|
|
2022
Q1 | $1.27M | Hold |
24,500
| – | – | 0.29% | 49 |
|
|
2021
Q4 | $1.45M | Hold |
24,500
| – | – | 0.3% | 45 |
|
|
2021
Q3 | $1.05M | Hold |
24,500
| – | – | 0.24% | 49 |
|
|
2021
Q2 | $959K | Sell |
24,500
-24,000
| -49% | -$933K | 0.22% | 50 |
|
|
2021
Q1 | $1.76M | Hold |
48,500
| – | – | 0.42% | 44 |
|
|
2020
Q4 | $1.78M | Sell |
48,500
-2,619
| -5% | -$96.1K | 0.44% | 44 |
|
|
2020
Q3 | $1.78M | Hold |
51,119
| – | – | 0.48% | 46 |
|
|
2020
Q2 | $1.59M | Hold |
51,119
| – | – | 0.48% | 46 |
|
|
2020
Q1 | $1.58M | Sell |
51,119
-49,538
| -49% | -$1.69M | 0.61% | 42 |
|
|
2019
Q4 | $3.74M | Hold |
100,657
| – | – | 1.24% | 35 |
|
|
2019
Q3 | $3.43M | Hold |
100,657
| – | – | 1.22% | 34 |
|
|
2019
Q2 | $4.14M | Hold |
100,657
| – | – | 1.44% | 28 |
|
|
2019
Q1 | $4.06M | Hold |
100,657
| – | – | 1.47% | 28 |
|
|
2018
Q4 | $4.17M | Sell |
100,657
-17,387
| -15% | -$722K | 1.8% | 25 |
|
|
2018
Q3 | $4.94M | Hold |
118,044
| – | – | 1.8% | 25 |
|
|
2018
Q2 | $4.06M | Sell |
118,044
-7,641
| -6% | -$261K | 1.62% | 30 |
|
|
2018
Q1 | $4.23M | Hold |
125,685
| – | – | 1.67% | 29 |
|
|
2017
Q4 | $4.32M | Sell |
125,685
-115,940
| -48% | -$3.95M | 1.71% | 22 |
|
|
2017
Q3 | $8.18M | Hold |
241,625
| – | – | 3.22% | 7 |
|
|
2017
Q2 | $7.7M | Hold |
241,625
| – | – | 3.05% | 6 |
|
|
2017
Q1 | $7.84M | Hold |
241,625
| – | – | 3.19% | 5 |
|
|
2016
Q4 | $7.45M | Hold |
241,625
| – | – | 3.29% | 6 |
|
|
2016
Q3 | $7.76M | Hold |
241,625
| – | – | 3.34% | 6 |
|
|
2016
Q2 | $8.07M | Hold |
241,625
| – | – | 3.6% | 6 |
|
|
2016
Q1 | $6.79M | Hold |
241,625
| – | – | 3.09% | 8 |
|
|
2015
Q4 | $7.4M | Buy |
+241,625
| New | +$7.6M | 3.31% | 5 |
|
Other funds holding PFE
TIM
Chad R. Baker's PFE Position: Q1 2025 in Review
Chad R. Baker sold out of Pfizer (PFE) in Q1 2025, closing a stake of 12,500 shares — an estimated $332K sold.
Chad R. Baker first reported a position in PFE in Q4 2015 and held it in 37 quarters. The position peaked at $8.18M in Q3 2017. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.
- Chad R. Baker reported no remaining Pfizer position as of Q1 2025 after selling out during the quarter.
- Chad R. Baker sold 12,500 Pfizer shares in Q1 2025, an estimated $332K.
- Chad R. Baker first reported a position in Pfizer in Q4 2015 and held it in 37 quarters.
- Chad R. Baker's Pfizer position peaked at $8.18M in Q3 2017.
- 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.
Based on Chad R. Baker's 13F filing for Q1 2025, filed 16 Apr 2025.